Scientific Advice

We can support companies wishing to elicit scientific advice from HTA agencies on their clinical, economic and humanistic (PRO) evidence generation strategies on assets entering into phase 2 and phase 3 development

access expert advice
from industry experts

Oncology Access Solutions Ltd has years of experience guiding global product teams through the process of eliciting scientific advice from HTA agencies. This has involved developing briefing books and company positions on proposed clinical trial designs, real-world evidence strategies and proposed structures for health economic models, as well as helping lead discussions during the meetings and writing detailed minutes.

$375bnexpected spending total on cancer medicines by 2027

5%global increase number of treated patients over the past five years

2,000oncology products currently under development

a consultancy you can trust

we are  
industry experts

we are
dedicated

we are
patient-centric

a wealth of life science
knowledge and expertise

Oncology Access Solutions Ltd is led and founded by Dr Clare Hague – a highly experienced health economist and health services researcher with a strong industry and academic background.

With over 18 years of industry experience with large, mid-sized and start-up biotech companies, we Clare is a seasoned and knowledgeable independent consultant able to provide a discreet and dedicated service.

Learn more